Publications by authors named "Christopher Stokoe"

Claim this Profile
M
Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature.
Megan L Kruse, Irene M Kang, Nusayba A Bagegni, W Todd Howell, Halle C F Moore, Christopher T Stokoe

Oncol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
Louis Fehrenbacher, Reena S Cecchini, Charles E Geyer, Priya Rastogi, Joseph P Costantino, Christopher Stokoe

J Clin Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine.
Joyce O'Shaughnessy, Hartmut Koeppen, Yuanyuan Xiao, Mark R Lackner, Devchand Paul, Christopher Stokoe

Clin Cancer Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Stephen E Jones, Rufus Collea, Devchand Paul, Scot Sedlacek, Anne M Favret, Christopher Stokoe

Lancet Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy.
John Pippen, Anthony D Elias, Marcus Neubauer, Christopher Stokoe, LaTrice G Vaughn

Clin Breast Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapting Practice in the Face of New Data.
Christopher Stokoe

J Oncol Pract· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
Stephen Jones, Christopher Stokoe, Mark Sborov, Marcus Braun, Sukumar Ethirajan

Clin Breast Cancer· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis